Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$646M |
| 2 |
Tesla
TSLA
|
+$572M |
| 3 |
Broadcom
AVGO
|
+$521M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$478M |
| 5 |
lululemon athletica
LULU
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$861M |
| 3 |
Palantir
PLTR
|
+$730M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$576M |
| 5 |
NVIDIA
NVDA
|
+$443M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.35% |
| 2 | Technology | 1.74% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Financials | 0.71% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DTCX
11851
Datacentrex Inc
DTCX
$104M
| $51.3K | ﹤0.01% |
+10,267
| New | +$90.2K |
|
11852
Cryo-Cell International
CCEL
$32.3M
| $51.3K | ﹤0.01% |
+11,062
| New | +$52.5K |
|
11853
PUT
Opko Health
OPK
$1.1B
| $51.3K | ﹤0.01% |
33,100
-35,100
| -51% | -$48.2K |
|
11854
CALL
Savara
SVRA
$1.08B
| $51.1K | ﹤0.01% |
14,300
-10,400
| -42% | -$30.8K |
|
11855
CALL
Caribou Biosciences
CRBU
$174M
| $51K | ﹤0.01% |
21,900
+7,600
| +53% | +$14.3K |
|
11856
Quetta Acquisition Corp Right
QETAR
| $50.7K | ﹤0.01% |
25,611
+9,142
| +56% | +$15.9K |
|
11857
CXApp
CXAI
$8.44M
| $50.6K | ﹤0.01% |
+1,373
| New | +$59.6K |
|
11858
PUT
Agilon Health
AGL
$1.55B
| $50.4K | ﹤0.01% |
1,956
-272
| -12% | -$10.3K |
|
|
JF
11859
J and Friends Holdings
JF
$17.4M
| $50.3K | ﹤0.01% |
53,079
-180,690
| -77% | -$175K |
|
11860
BioCardia
BCDA
$17.4M
| $50.1K | ﹤0.01% |
38,808
| – | – |
|
11861
Recon Technology
RCON
$725K
| $49.8K | ﹤0.01% |
+126
| New | +$61.1K |
|
11862
PUT
Westrock Coffee
WEST
$781M
| $49.6K | ﹤0.01% |
10,200
-29,900
| -75% | -$180K |
|
11863
CALL
AdvisorShares Pure Cannabis ETF
YOLO
$36.4M
| $49.4K | ﹤0.01% |
+14,000
| New | +$39K |
|
11864
Loop Industries
LOOP
$25.3M
| $49.4K | ﹤0.01% |
+33,383
| New | +$51K |
|
11865
PUT
Lineage Cell Therapeutics
LCTX
$281M
| $49.2K | ﹤0.01% |
+29,100
| New | +$34.4K |
|
11866
PUT
Annexon
ANNX
$942M
| $49.1K | ﹤0.01% |
16,100
-11,300
| -41% | -$28.1K |
|
11867
Nephros
NEPH
$49.4M
| $49.1K | ﹤0.01% |
10,373
-19,052
| -65% | -$74.8K |
|
|
SFHG
11868
Samfine Creation Holdings
SFHG
$9.7M
| $48.8K | ﹤0.01% |
+13,736
| New | +$53.3K |
|
|
MGF
11869
Aberdeen Government Markets Income Fund
MGF
$93.9M
| $48.7K | ﹤0.01% |
+15,612
| New | +$48.2K |
|
|
VIVO
11870
CALL
VivoPower PLC
VIVO
$125M
| $48.6K | ﹤0.01% |
+10,800
| New | +$55.8K |
|
11871
CALL
Rimini Street
RMNI
$527M
| $48.2K | ﹤0.01% |
10,300
+200
| +2% | +$888 |
|
11872
Myomo
MYO
$63.4M
| $48.1K | ﹤0.01% |
53,872
-525
| -1% | -$764 |
|
11873
Vista Gold
VGZ
$323M
| $48.1K | ﹤0.01% |
22,560
+12,144
| +117% | +$15.8K |
|
|
UCL
11874
uCloudlink Group
UCL
$14.6M
| $48K | ﹤0.01% |
+22,099
| New | +$60.4K |
|
11875
CALL
Pyxis Oncology
PYXS
$269M
| $47.7K | ﹤0.01% |
+21,500
| New | +$31K |
|
Similar funds
Jeff Yass's Q3 2025 Portfolio in Review
As of Q3 2025, Jeff Yass held 14,336 positions worth $875B, up 22% from $720B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q3 2025 filing shows 1,794 new, 5,240 increased, 5,148 reduced and 2,105 closed positions. Its largest new stake was BitMine Immersion Technologies: 7,689,603 shares worth $399M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2025 buy was BitMine Immersion Technologies: 7,689,603 shares worth $399M.
- Jeff Yass added most to Meta Platforms (Facebook) in Q3 2025, an estimated $646M increase.
- Jeff Yass's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Jeff Yass fully exited iShares Core MSCI Total International Stock ETF in Q3 2025, selling an estimated $123M.
- Jeff Yass's ten largest holdings make up 24% of its $875B portfolio in Q3 2025.
- Jeff Yass opened 1,794 new positions and closed 2,105 in Q3 2025.
- Jeff Yass's portfolio value rose 22% quarter-over-quarter to $875B.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.